← Open Payments lookup

ANA ESCOBEDO: Open Payments

NPI 1912407578 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$730 in 35 payments from 15 companies in 2025. Trend: 2023 $467 · 2024 $891 · 2025 $730

Food & beverage: $730
CompanyPaymentsAmount
Novo Nordisk Inc13$177
AstraZeneca Pharmaceuticals LP4$150
PFIZER INC.3$73
SANOFI PASTEUR INC.2$59
Boston Scientific Corporation1$43
Dexcom, Inc.2$35
Astellas Pharma US Inc2$28
SHIELD THERAPEUTICS INC1$23
Averitas Pharma Inc.1$23
Boehringer Ingelheim Pharmaceuticals, Inc.1$22

Products named: FARXIGA, Ozempic, PREVNAR 20, Wegovy, APOLLO ESG System, FLUZONE HIGH-DOSE, Dexcom G6 Transmitter, Veozah.

Industry payments across TX — which companies pay providers there.